Evidence map›Paper›PMID 42796684›Full record

ArticlePathogens (Basel, Switzerland)2026

Environmental Surveillance of Poliovirus in the Democratic Republic of the Congo: Sensitivity and Site Productivity, 2017-2025.

Vanessa Bakumba-Kiulu, Paul Tshiminyi-Munkamba, Trésor Kabeya-Mampuela, Meris Matondo-Kuamfumu, Grace Kashitu-Mujinga, Junior Bulabula-Penge, Elisabeth Pukuta-Nsimbu, Elysabeth Muyamuna-Mulongo, Yvonne Lay Mowele, Jean Claude Mukangala-Changa-Changa and 4 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vanessa Bakumba-KiuluService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.
Paul Tshiminyi-MunkambaDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Trésor Kabeya-MampuelaService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.ORCID 0009-0001-0526-9389
Meris Matondo-KuamfumuService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.
Grace Kashitu-MujingaService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.ORCID 0009-0007-2754-6379
Junior Bulabula-PengeDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.ORCID 0009-0009-4742-7419
Elisabeth Pukuta-NsimbuDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Elysabeth Muyamuna-MulongoDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Yvonne Lay MoweleDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Jean Claude Mukangala-Changa-ChangaDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Eddy Kinganda-LusamakiService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.ORCID 0000-0001-9795-0165
Narcisse Yogolelo-RizikiDepartment of Virology, Institut National de Recherche Biomédicale (INRB), Kinshasa 01204, Democratic Republic of the Congo.
Antoine Nkuba-NdayeService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.ORCID 0000-0003-2850-7498
Steve Ahuka-MundekeService of Microbiology, Department of Medical Biology, Kinshasa Teaching School of Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa BP 125, Democratic Republic of the Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnvironmental surveillance (ES) of wastewater was introduced by the Global Polio Eradication Initiative (GPEI) to improve the sensitivity of acute flaccid paralysis (AFP) surveillance. In the Democratic Republic of the Congo (DRC), ES for poliovirus has been implemented since 2017. This study assessed its sensitivity and productivity.

methodsA retrospective descriptive study using ES for poliovirus data collected in the DRC between September 2017 and June 2025. Wastewater samples were analyzed at the National Institute for Biomedical Research (INRB), using a standardized algorithm that included concentration, cell culture, real-time reverse transcription polymerase chain reaction (rRT-PCR), and VP1 sequencing. Site sensitivity was assessed by productivity, defined as a viral isolation rate ≥ 50%.

resultsA total of 2491 wastewater samples were collected. ES expanded from 6 sites in 3 provinces to 27 sites across 8 provinces. Overall site productivity was 33.9% (846/2491 cultures positive for enteroviruses), showing significant variability between sites and over time, which sometimes led to site closures. Non-polio enteroviruses were the most commonly isolated viruses. Among poliovirus isolates, Sabin-like strains (types 1, 2, and 3), novel oral poliovirus vaccine type 2 (nOPV2), and vaccine-derived poliovirus type 2 (VDPV2) were identified, with VDPV2 representing 13.1%. No wild poliovirus was detected.

conclusionES for poliovirus has expanded in the DRC, helping detect vaccine-derived poliovirus circulation and confirming the absence of wild poliovirus. Despite ongoing operational and logistical challenges causing fluctuations in site productivity, this study emphasizes the vital role of ES as a supplement to AFP surveillance.

Indexed as

Environmental MonitoringPoliomyelitisPoliovirusWastewaterDemocratic Republic of the CongoHumansRetrospective StudiesWastewaterDemocratic Republic of the Congoenvironmental surveillancepoliovirus

Identifiers

PMID42796684
PMCPMC13610432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.